{"entity":{"type":"insider","cik":"0001316163","url":"/insider/0001316163","json_url":"/insider/0001316163.json","name":"Colowick Alan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2020-05-05","last":"2025-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Colowick Alan","source":"filing","n_filings":3,"first_seen":"2020-05-05","last_seen":"2025-04-03"}],"transactions":[{"id":4281066,"accession":"0001415889-25-010050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-010050","line_url":"/filing/0001415889-25-010050#line-2","is_derivative":false,"issuer_cik":"0001316163","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001316163","owner_cik":"0001316163","owner_name":"Colowick Alan","owner_display_name":"Colowick Alan","owner_url":"/insider/0001316163","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":7.4935,"price_display":"7.49","price_state":"stated","total_value":17235.05,"total_display":"17,235.05","total_whole":"17,235","shares_owned_after":18404.0,"shares_owned_after_display":"18,404","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-03","scope":"insider"},{"id":4281063,"accession":"0001415889-25-010050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-010050","line_url":"/filing/0001415889-25-010050#line-1","is_derivative":false,"issuer_cik":"0001316163","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001316163","owner_cik":"0001316163","owner_name":"Colowick Alan","owner_display_name":"Colowick Alan","owner_url":"/insider/0001316163","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16104.0,"shares_display":"16,104","price_per_share":6.974,"price_display":"6.97","price_state":"stated","total_value":112309.296,"total_display":"112,309.30","total_whole":"112,309","shares_owned_after":16104.0,"shares_owned_after_display":"16,104","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":3115559,"accession":"0001209191-20-040793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-040793","line_url":"/filing/0001209191-20-040793#line-2","is_derivative":false,"issuer_cik":"0001316163","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001316163","owner_cik":"0001316163","owner_name":"Colowick Alan","owner_display_name":"Colowick Alan","owner_url":"/insider/0001316163","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2879612,"accession":"0001209191-20-027348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-027348","line_url":"/filing/0001209191-20-027348#line-4","is_derivative":false,"issuer_cik":"0001316163","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001316163","owner_cik":"0001316163","owner_name":"Colowick Alan","owner_display_name":"Colowick Alan","owner_url":"/insider/0001316163","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6660.0,"shares_display":"6,660","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":399600.0,"total_display":"399,600.00","total_whole":"399,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-05","scope":"insider"},{"id":2879602,"accession":"0001209191-20-027348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-027348","line_url":"/filing/0001209191-20-027348#line-2","is_derivative":false,"issuer_cik":"0001316163","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001316163","owner_cik":"0001316163","owner_name":"Colowick Alan","owner_display_name":"Colowick Alan","owner_url":"/insider/0001316163","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":840.0,"shares_display":"840","price_per_share":60.0675,"price_display":"60.07","price_state":"stated","total_value":50456.7,"total_display":"50,456.70","total_whole":"50,457","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-01","filed_date":"2020-05-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847367","name":"ALUMIS INC.","url":"/issuer/0001847367","role":"Director","n_filings":1,"first_seen":"2025-04-03","last_seen":"2025-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Director","n_filings":2,"first_seen":"2020-05-05","last_seen":"2020-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001316163","retrieved_at":"2026-08-23T19:14:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}